Cardiovascular diseases remain the leading cause of mortality globally, encompassing a range of disorders that affect the heart and blood vessels, including but not limited to ischemic heart disease, ...

Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, College of Medicine or College of Pharmacy ...

Latrophilin-2 (Lphn2), an adhesive GPCR (G protein-coupled receptor), was found to be a specific marker of cardiac progenitors during the differentiation of pluripotent stem cells into cardiomyocytes ...

Announcing a new publication for Acta Materia Medica journal. Herba Siegesbeckiae (HS) has been traditionally used for ...

"This technology will allow us to get the right drug, to the right person, at the right time," says Maynes, Chief of the Department of Anesthesia and Pain Medicine, Associate Chief of Research for ...

These complications are caused by intrinsic defects in cardiomyocyte and cardiac conduction system function, and by the presence of severe skeletal muscle disease, which also contributes to ...

In a recent study, the regulatory role of the long noncoding RNA (lncRNA) Gm20257 in pathological cardiac hypertrophy has ...

University of Queensland-led research has found inflammatory markers in the blood of long COVID patients which could explain ...

Unlike most cells in the human body, stem cells have the unique ability to divide indefinitely. This property makes them ...

Cardiac hypertrophy is the abnormal enlargement, or thickening, of the heart muscle, resulting from increases in cardiomyocyte size and changes in other heart muscle components, such as ...